AIM ImmunoTech Inc
F:HXB2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AIM ImmunoTech Inc
F:HXB2
|
US |
|
B
|
Braemar Shipping Services PLC
OTC:BSEAF
|
UK |
|
I
|
IMPACT Growth Real Estate Investment Trust
SET:IMPACT
|
TH |
|
Lu-Ve SpA
MIL:LUVE
|
IT |
|
N
|
Northrop Grumman Corp
XMUN:NTH
|
US |
|
C
|
CME Group Inc
XMUN:MX4A
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HXB2's stock price target?
Not Available
HXB2 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for AIM ImmunoTech Inc?
Projected CAGR
154%
Over the last 14 years, the compound annual growth rate for Revenue has been -4%. The projected CAGR for the next 8 years is 154%.